[Effect of dopamine and its antagonists on contractile activity of the lower esophageal sphincter and the stomach (author's transl)].

Effect of dopamine and its antagonists, domperidone and metoclopramide (MCP), on contractile activity of the lower esophageal sphincter (LES) and the stomach was studied in 5 healthy conscious dogs. Contractile activity was measured by means of chronically implanted force transducers. Contractile activity of the LES and the stomach was completely inhibited by an intravenous infusion of dopamine (10, 20 and 40 micrograms/kg-min) during the digestive and interdigestive state. Domperidone, when administered alone (0.5, 1.0 and 2.0 mg/kg), had no effect on contractile activity of the LES and the stomach during the both periods. Though deprived of any noticeable effect on the digestive contractions, MCP (0.25, 0.5 and 1.0 mg/kg) abolished the interdigestive contractions and produced characteristic contractions. Domperidone restored postprandial and interdigestive contractions to their initial stage before dopamine administration in a dose-related fashion. Dopamine-induced inhibition was antagonized by MCP during the digestive state, however, MCP had no effect on the interdigestive contractions that had been inhibited by dopamine. Since domperidone has no activity upon normal contractions of the gastrointestinal tract, it may be assumed that if domperidone alone has some influence upon gut motor activity or any improvement in clinical symptoms is seen after domperidone, a disorder of the dopaminergic system could be strongly suggested.